OrthoPediatrics’ (KIDS) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research report released on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $42.00 target price on the stock.

Separately, Truist Financial cut their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th.

OrthoPediatrics Stock Performance

KIDS opened at $23.55 on Tuesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The stock has a market capitalization of $570.29 million, a price-to-earnings ratio of -19.15 and a beta of 1.14. The company has a fifty day moving average of $24.07 and a 200 day moving average of $27.38. OrthoPediatrics has a fifty-two week low of $21.02 and a fifty-two week high of $35.99.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Quarry LP bought a new position in OrthoPediatrics during the third quarter valued at $25,000. International Assets Investment Management LLC increased its holdings in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after buying an additional 966 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of OrthoPediatrics during the 2nd quarter valued at about $34,000. BNP Paribas Financial Markets lifted its holdings in shares of OrthoPediatrics by 125.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after acquiring an additional 1,929 shares during the last quarter. Finally, Quantbot Technologies LP grew its position in OrthoPediatrics by 42.2% in the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after acquiring an additional 1,712 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.